COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with COPD (a long-term lung condition), confirmed by a specific breathing test showing reduced airflow that does not improve with an inhaler
- People who have ongoing breathing difficulties due to low oxygen levels in the blood, even when resting and breathing normal air
- People who have been using long-term home oxygen therapy for at least 3 months
- People whose condition is currently stable, with normal blood acidity levels, no flare-ups in the last 7 days, and no changes to their medications in the last 7 days
Who may not be able to join:
- People who use a breathing support machine (non-invasive ventilation) at home
- People who have significant memory or thinking difficulties, assessed using a standard cognitive test
- People who have asthma, or whose breathing shows a meaningful improvement after using an inhaler
- People who have scarring or stiffening of the lung tissue (pulmonary fibrosis)
- People who have obstructive sleep apnea (a condition where breathing repeatedly stops during sleep)
- People who have lung cancer
- People who currently have an active infection caused by bacteria, viruses, or other microbes
- People who have nerve, muscle, bone, or other physical conditions that would prevent them from completing the trial's tests or activities
- People who have taken part in a lung rehabilitation program within the last 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michele Vitacca, MD, ICS Maugeri IRCCS, respiratory rehabilitation of the Institute of Lumezzane
Phone: 0039+030+8253
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in effort tolerance at 6 minutes walking test: Minimal Clinical Important Difference (MCID) at 6MWT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.